Latest Press Releases
View all
TimeHeadline
5m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
38m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
38m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
38m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
38m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Phio Pharmaceuticals Corp logo

Phio Pharmaceuticals Corp

About

Phio Pharmaceuticals Corp (NASDAQ:PHIO) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 13 2026
Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
Apr 9 2026
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
Mar 30 2026
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
Mar 23 2026
Phio Pharmaceuticals Announces American Academy of Dermatology 2026 Presentation Featuring Clinical Study Results from Study of PH-762 for Cutaneous Carcinoma Underscoring Clinical Pipeline Advancement
Mar 16 2026
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office

Financials

Revenue
$0
Market Cap
$14.64 M
EPS
-1.45

Community Chat

Ask AI

6ix6ixAIEvents